Pharma News

pharma courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Drugs for Rare Diseases - New Brunswick Agreement
    21 January 2025

    Drugs for Rare Diseases - New Brunswick Agreement

    The Governments of Canada and the province of New Brunswick signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over 32 million USD over three years to improve access to new drugs for rare diseases for New Brunswick residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.

  • 21 January 2025
    Glenmark Pharma USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules
    Glenmark Pharmaceuticals Inc., USA announces the launch1 of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules. Glenmark’s Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL of Hospira, Inc., ANDA 087955.
  • 21 January 2025
    US exits WHO, Trump signs executive order

    US withdraws from WHO after mishandling of the COVID-19 pandemic from WHO and signs executive order.

    The United States noticed its withdrawal from the World Health Organization (WHO) in 2020 due to the organization’s mishandling of the COVID-19 pandemic that arose out of Wuhan, China, and other global health crises, its failure to adopt urgently needed reforms, and its inability to demonstrate independence from the inappropriate political influence of WHO member states.

  • 20 January 2025
    Florescent Probes Illuminate Cholesterol and Alzheimer’s Research
    The search for answers to Alzheimers disease and other neurodegenerative disorders remains one of the most pressing goals in brain research. Maciej J. Stawikowski, Ph.D., an assistant professor of chemistry and biochemistry at Florida Atlantic Universitys Charles E. Schmidt College of Science, believes the key may lie in understanding how cholesterol and other lipids move through cells and affect their communication.
  • 20 January 2025
    Brain changes in Huntington’s disease decades before diagnosis will guide future prevention trials

    Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately twenty years before a clinical motor diagnosis in people with Huntington’s disease, finds a new study led by UCL researchers.

  • 8 January 2025
    Five years to COVID-19 Pandemic
    Five years ago on 31 December 2019, WHOs Country Office in China picked up a media statement by the Wuhan Municipal Health Commission from their website on cases of viral pneumonia in Wuhan, China. In the weeks, months and years that unfolded after that, COVID-19 came to shape our lives and our world.
  • 8 January 2025
    Sentynl Therapeutics announces USFDA Acceptance and Priority Review of NDA for CUTX-101
    Sentynl Therapeutics, Inc. a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd and Fortress Biotech, Inc. announced that the U.S. Food and Drug Administration has accepted for filing and Priority review Sentynls New Drug Application for CUTX-101
  • 8 January 2025
    Zydus agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR

    Zydus Lifesciences Ltd. a global innovation driven healthcare company announced that it has entered into an agreement with CVS Caremark®, a CVS Health® (NYSE: CVS) company to add ZituvioTM , ZituvimetTM and ZituvimetTM XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) tablets to its template formulary.

    CVS Caremark will add Zydus’ ZituvioTM and combination products to its template formulary starting January 1, 2025.

  • 4 January 2025
    Detecting disease with only a single molecule

    UC Riverside scientists have developed a nanopore-based tool that could help diagnose illnesses much faster and with greater precision than current tests allow, by capturing signals from individual molecules.

  • 4 January 2025
    HKUMed confirms clozapine safety with first big-data evidence on rare blood cancer cases
    An inter-departmental research team at the LKS Faculty of Medicine of the University of Hong Kong has conducted the world’s first analytic real-world cohort study on the association of clozapine, a highly efficacious antipsychotic drug, with the incidence of blood cancer.
Subscribe to Pharma News